Featured

Banned From Cureus: How To Avoid Hearing Those Dreaded Words

In the current political climate there is a lot of discussion these days about banning certain immigrant groups. As a point of principle, Cureus welcomes physicians of all races, nationalities, religions or gender and sexual identities to use our FREE publication platform.

Because we believe access to medical knowledge is a fundamental human right, Cureus aspires to break down all barriers to the freer dissemination of medical knowledge, especially for physician authors in developing countries. No matter who you are, if you have credible medical science you wish to publish conscientiously and in good faith, while following Cureus’ submission guidelines, our journal is committed to serving you.

banned

However, if you are a physician for whom publishing is merely a vanity project or a tool for professional advancement, with little regard for the integrity of the process, Cureus specifically does not want your content. If you are the type of individual who chooses to take shortcuts with the truth, who sees nothing wrong with plagiarism or scientific fraud, please stay away from Cureus.

You are hereby warned that if you are caught abusing our generous spirit, we will, to the best of our abilities, ultimately ban you AND your co-authors from further access to our journal AND when appropriate, (plagiarism and academic fraud) we will aggressively pursue academic censor from the offending individual’s parent academic or clinical institution.

Please be forewarned that our editorial team does not take lightly to authors that betray the truth or Cureus’ generosity. Our team has on a few past occasions, including very recently, needed to report serious infringements of our policies to the appropriate academic authorities. So ultimately the answer is yes, one can be BANNED from Cureus. Don’t be one of those people!

Announcing the Winners of the Negative Pressure Wound Therapy Publishing Competition!

kci-acelity-npwtid-email-winners-announced

The SIQ scoring period has ended and the scores have been tabulated. We are pleased to announce the following articles as winners of the Negative Pressure Wound Therapy with Instillation publishing competition:

1st place – 8.3 SIQ ($5,000): “Negative Pressure Wound Therapy with Instillation in a Chronic Non-Healing Right Hip Trochanteric Pressure Ulcer” by Broder, Nguyen and Broder

2nd place – 8.0 SIQ ($2,000): “A Case Review Series of Christiana Care Health System’s Experience with Negative Pressure Wound Therapy Instillation” by Felte, Gallagher, Tinkoff and Cipolle

3rd place – 7.0 SIQ ($1,000): “Utilizing the VeraFlo™ Instillation Negative Pressure Wound Therapy System with Advanced Care for a Case Study” by Rita K. Driver

We’ll be reaching out to the corresponding author of each article to arrange for award delivery.

As is the case with all of our publishing competitions, please keep in mind that only scores submitted during the competition scoring period are included when determining the winners.

We’d like to extend a big thank you to the Cureus community for their efforts in reading and scoring competition articles over the past few months. Without you, this competition would not be possible.

And remember – even though the competition is over, you can still access and score all of the articles. Thanks for your support!

Optimization Strategies for Organ Donation and Utilization Competition Winners!

novartis-donate-life-email-winners-announcedThe SIQ scoring period has ended and the scores have been tabulated. We are pleased to announce the following articles as winners of the Optimization Strategies for Organ Donation and Utilization publishing competition:

Winner, Organ Utilization – 9.3 SIQ: Trends in Usage and Outcomes for Expanded Criteria Donor Kidney Transplantation in the United States Characterized by Kidney Donor Profile Index” by Rege, Irish, Castleberry et al.

Winner, Organ Donation – 5.5 SIQ: “Envisioning and Leading Organizational Transformation: One Organ Procurement Organization’s Journey” by Orlowski

As a reward for their efforts, each author group will be awarded $5,000. (We’ll be reaching out to the corresponding author of each article to arrange for award delivery.)

As is the case with all of our publishing competitions, please keep in mind that the above scores represent only those scores submitted during the competition scoring period.

We’d like to extend a big thank you to the Cureus community for their efforts in reading and scoring competition articles over the past few months. Without you, this competition would not be possible.

And remember – even though the competition is over, you can still access and score all of the articles. Thanks for your support!

Autologous Epidermal Grafting: Announcing the Competition Winner!

kci-competition-email-winners-announcedThe SIQ scoring period has ended and the scores have been tabulated. We are pleased to announce the following articles as winners of the Clinical and Economic Benefits of Autologous Epidermal Grafting publishing competition:

1st place, 9.3 SIQ: “Clinical and Economic Benefits of Autologous Epidermal Grafting” by Maderal & Kirsner

2nd place, 9.0 SIQ: “A Case Series of Complex Recalcitrant Wounds Treated with Epidermal Grafts Harvested from an Automated Device” by Cai, Gowda, Chopra et al.

3rd place, 6.0 SIQ: “Autologous Epidermal Grafting Using a Novel Negative Pressure Epidermal Harvesting System in a Case of Stable Vitiligoby” by Krishna, Thirunavukkarasu, Krishnan et al.

As you can see, the battle for first place came down to the wire with only a handful of scores separating first and second place. (Keep in mind that the above scores represent only those scores submitted during the competition scoring period.)

We’d like to extend a big thank you to the Cureus community for their efforts in reading and scoring competition articles over the past few months. Without you, this competition would not be possible.

And remember – even though the competition is over, you can still access and score all of the articles. Thanks for your support!

Announcing a New Editorial Policy Regarding Submission Quality

Cureus operates a free, merit-based publication system, in which we publish all articles that satisfy our requirements and contain no fraudulent or dangerous science. It is therefore the responsibility of the submitting author to meet us halfway by submitting an article draft that meets all listed requirements. Over the past several months, we’ve noticed an influx of submissions containing sloppy and careless work, much of it concerning figures and references. We’re a small team with limited editorial resources and, in exchange for offering free publication, we expect our authors to submit work that meets our requirements. (Requirements that are still quite streamlined compared to other journals, such as PeerJ.)

That is why, effective immediately, authors will have only two chances to submit a draft meeting all Cureus publishing requirements (as detailed below). Submitting an unacceptable draft will result in an editor-issued deferral. Once deferred, the author will be tasked with revising the article based on editor instructions before resubmitting.

If a second deferral follows (due to the author failing to follow editor instructions), the article draft will no longer be eligible for peer review (and publication within Cureus). This only applies to deferrals before peer review. Post peer review deferrals will not be counted against the author.

Additionally, if a submitting author has two drafts ruled permanently ineligible, as described above, he or she will no longer be permitted to publish in Cureus.

We pledge to work closely with all of our submitting authors to avoid such a scenario, but unfortunately we’ve reached a point where we must institute stricter submission enforcement due to the many poorly formatted and incomplete drafts we are receiving.

If you have concerns or questions regarding this change, please reach out to us at info@cureus.com and a Cureus team member will get back to you ASAP.

Optimizing for Mobile Users: Cureus Rolls Out Responsive Design

Roughly 25% of our community accesses Cureus via a mobile or tablet device. We’re not in the business of ignoring our users, which is why we’re happy to announce our new responsive design rollout. What is responsive design? To put it in plain terms, a responsive webpage will look great no matter how large or small your screen. When viewed on a phone (or even just a small browser window on your laptop), the page design will rearrange itself to give you, the reader, the best viewing experience. (For a more detailed response, check out this great piece by John Polacek.)

Desktop view (left) vs. Mobile view (right)
Desktop view (left) vs. Mobile view (right)

Since submitting an article draft doesn’t translate well to mobile (and really, who wants to do all of that on their phone?), this will remain a non-responsive process, designed to be completed on a desktop or laptop computer. Reading and scoring articles, posters and abstracts, however, is a perfect fit for our mobile and tablet users – and it just became easier than ever with our newly released page designs.

Quickly hop into an article on your phone with no need to resize the page or struggle with small buttons or text. Now you can read, score and share whenever you have a moment. We know how busy you are – perhaps your evening train commute is the best time for you to be active in the Cureus community. Or maybe you prefer to check out the latest published articles while relaxing in your yard. Whatever the case may be, you’ll be able to do it on your phone or tablet.

We’ll be making more pages responsive just as soon as we can – so stay tuned for more updates! Questions or comments? Shoot us an email at info@cureus.com.

Calling All Academic Departments: It’s Time to Share Your Hard Work With the World

Close your eyes and picture the following (it probably won’t be difficult):

Your academic department is full of hard-working researchers and practicing physicians. Cutting edge research and innovative clinical experiences are everywhere. Trusted veteran physicians and up-and-coming stars are working together. All of your department’s faculty and residents know that their collective work is making a difference. Worthy of praise, funding and patient referrals.

But does anyone else know?

By partnering with Cureus you can ensure that fellow physicians around the world are updated on the latest and greatest from your department. All Cureus channel partners receive their very own branded, quarterly email digests that are managed and sent by Cureus.

Featuring hand-picked, recently published articles from your department as well as author head shots, a Cureus quarterly digest is an excellent way to raise awareness surrounding your department, boost the profile of up-and-coming faculty and even gain patient referrals.

We invite each of our channel partners to customize their quarterly’s messaging to fit their department’s unique goals. With thousands of recipients and sky-high open and click rates, we’re confident that a Cureus quarterly digest is the best value for your department’s marketing budget. Take a look at the examples below, and contact us at info@cureus.com to learn how your department can reach physicians and researchers around the world.

Note: partial view of quarterly digest.
Note: partial view of quarterly digest.
Note: partial view of quarterly digest.
Note: partial view of quarterly digest.